| review article | Q7318358 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1007/S000180050320 |
| P698 | PubMed publication ID | 10357232 |
| P2093 | author name string | Bode W | |
| Grams F | |||
| Maskos K | |||
| Nagase H | |||
| Tschesche H | |||
| Fernandez-Catalan C | |||
| P433 | issue | 4 | |
| P304 | page(s) | 639-652 | |
| P577 | publication date | 1999-04-01 | |
| P1433 | published in | Cellular and Molecular Life Sciences | Q5058352 |
| P1476 | title | Structural properties of matrix metalloproteinases | |
| P478 | volume | 55 |
| Q44387089 | A quantitative structure-activity relationship study of hydroxamate matrix metalloproteinase inhibitors derived from functionalized 4-aminoprolines |
| Q33424570 | ADAMTS13 and von Willebrand factor interactions |
| Q26776128 | Accentuating and Opposing Factors Leading to Development of Thoracic Aortic Aneurysms Not Due to Genetic or Inherited Conditions |
| Q33498106 | Active-site determinants of substrate recognition by the metalloproteinases TACE and ADAM10 |
| Q43948600 | Anthranilate sulfonamide hydroxamate TACE inhibitors. Part 1: Structure-based design of novel acetylenic P1' groups |
| Q33837024 | Anti-photoaging and photoprotective compounds derived from marine organisms |
| Q37207369 | Applications of Tripodal [S(3)] and [Se(3)] L(2)X Donor Ligands to Zinc, Cadmium and Mercury Chemistry: Organometallic and Bioinorganic Perspectives |
| Q56883851 | Arthritis drug discovery |
| Q53212379 | Ascorbyl coumarates as multifunctional cosmeceutical agents that inhibit melanogenesis and enhance collagen synthesis. |
| Q28116011 | Biochemical and spectroscopic characterization of the catalytic domain of MMP16 (cdMMP16) |
| Q45044706 | Calcification and identification of metalloproteinases in bovine pericardium after subcutaneous implantation in rats. |
| Q27648164 | Catalytic domain of MMP20 (Enamelysin) - the NMR structure of a new matrix metalloproteinase |
| Q64975506 | Characterization and regulation of MT1-MMP cell surface-associated activity. |
| Q34631606 | Characterization of selective exosite-binding inhibitors of matrix metalloproteinase 13 that prevent articular cartilage degradation in vitro. |
| Q37059324 | Cloning, expression, purification and preliminary X-ray diffraction studies of a novel AB₅ toxin |
| Q36112629 | Comparison of Salivary TIMP-1 Levels in Periodontally Involved and Healthy Controls and the Response to Nonsurgical Periodontal Therapy |
| Q30483239 | Contributions of matrix metalloproteinases to neural plasticity, habituation, associative learning and drug addiction |
| Q27639102 | Crystal structure of human MMP9 in complex with a reverse hydroxamate inhibitor |
| Q55515529 | Cutting to the Chase: How Matrix Metalloproteinase-2 Activity Controls Breast-Cancer-to-Bone Metastasis. |
| Q51992983 | Differential regulation of MMPs and matrix assembly in chicken and turkey growth-plate chondrocytes. |
| Q35000708 | Discovery of chemokine substrates for matrix metalloproteinases by exosite scanning: a new tool for degradomics |
| Q40871740 | Effect of HPV on tumor expression levels of the most commonly used markers in HNSCC. |
| Q42833489 | Effect of hypoxia on stimulatory effect of TGF-beta 1 on MMP-2 and MMP-9 activities in mouse fibroblasts |
| Q45856745 | Electroporative interleukin-10 gene transfer ameliorates carbon tetrachloride-induced murine liver fibrosis by MMP and TIMP modulation |
| Q40656282 | Endostatin Inhibits Human Tongue Carcinoma Cell Invasion and Intravasation and Blocks the Activation of Matrix Metalloprotease-2, -9, and -13 |
| Q28571253 | Expression and localization of MT1-MMP and furin in the glomerular wall of short- and long-term diabetic rats |
| Q34508369 | Extracellular matrix molecules, long-term potentiation, memory consolidation and the brain angiotensin system |
| Q41046707 | Fluorescence detection of MMP-9. I. MMP-9 selectively cleaves Lys-Gly-Pro-Arg-Ser-Leu-Ser-Gly-Lys peptide |
| Q57713025 | Functional Proteomics on Zinc-Dependent Metalloproteinases using Inhibitor Probes |
| Q51771066 | Functional polymorphisms of matrix metallopeptidase-9 and risk of coronary artery disease in a Chinese population. |
| Q47752875 | Functional polymorphisms of matrix metalloproteinase-9 and survival in patients with locoregionally advanced nasopharyngeal carcinoma treated with chemoradiotherapy |
| Q36901061 | Functional proteomic analysis of seminal plasma proteins in men with various semen parameters |
| Q37664415 | Gardenia jasminoides Extract Attenuates the UVB-Induced Expressions of Cytokines in Keratinocytes and Indirectly Inhibits Matrix Metalloproteinase-1 Expression in Human Dermal Fibroblasts. |
| Q44051108 | Gelatinases in soft tissue biomaterials. Analysis of different crosslinking agents. |
| Q47932081 | Gingival fibroblast inhibits MMP-7: evaluation in an ex vivo aorta model |
| Q64057069 | Glomerular expression of matrix metalloproteinases in systemic lupus erythematosus in association with activity index and renal function |
| Q46748552 | Glucocorticoids alter craniofacial development and increase expression and activity of matrix metalloproteinases in developing zebrafish (Danio rerio). |
| Q34387735 | Hemopexin: a review of biological aspects and the role in laboratory medicine |
| Q28143236 | Hydrolysis of triple-helical collagen peptide models by matrix metalloproteinases |
| Q28139348 | Identification of the (183)RWTNNFREY(191) region as a critical segment of matrix metalloproteinase 1 for the expression of collagenolytic activity |
| Q38265490 | Implication of matrix metalloproteinases in regulating neuronal disorder |
| Q44375478 | Influence of flavonoids and vitamins on the MMP- and TIMP-expression of human dermal fibroblasts after UVA irradiation |
| Q40396352 | Inhibition of enzyme activity of and cell-mediated substrate cleavage by membrane type 1 matrix metalloproteinase by newly developed mercaptosulphide inhibitors |
| Q35313033 | Inhibition of matrix metalloproteinase 14 (MMP-14)-mediated cancer cell migration. |
| Q51219752 | Insulin increases gelatinase activity in rat glomerular mesangial cells via ERK- and PI-3 kinase-dependent signalling. |
| Q33959697 | Interactions between tumour cells and stromal cells and proteolytic modification of the extracellular matrix by metalloproteinases in cancer. |
| Q43560114 | Involvement of fibronectin type II repeats in the efficient inhibition of gelatinases A and B by long-chain unsaturated fatty acids. |
| Q35691003 | Key feature of the catalytic cycle of TNF-alpha converting enzyme involves communication between distal protein sites and the enzyme catalytic core |
| Q75219888 | Kinetic analysis of the binding of hemopexin-like domain of gelatinase B cloned and expressed in Pichia pastoris to tissue inhibitor of metalloproteinases-1 |
| Q34952815 | LL-37 in periodontal health and disease and its susceptibility to degradation by proteinases present in gingival crevicular fluid |
| Q46764755 | Leptin increases expression and activity of matrix metalloproteinase-2 and does not alter collagen production in rat glomerular mesangial cells |
| Q34232180 | Local conformation and dynamics of isoleucine in the collagenase cleavage site provide a recognition signal for matrix metalloproteinases. |
| Q33237044 | MMP-20 is predominately a tooth-specific enzyme with a deep catalytic pocket that hydrolyzes type V collagen |
| Q43790567 | MMP-TIMP interaction depends on residue 2 in TIMP-4. |
| Q45077001 | Mathematical modeling of collagen turnover in biological tissue |
| Q36125093 | Matrix Metalloproteinases and Bladder Cancer: What is New? |
| Q26741827 | Matrix Metalloproteinases in Non-Neoplastic Disorders |
| Q34002149 | Matrix metalloproteinase control of capillary morphogenesis |
| Q37024770 | Matrix metalloproteinase inhibitors based on the 3-mercaptopyrrolidine core |
| Q35032152 | Matrix metalloproteinase-9 in lung remodeling |
| Q34850104 | Matrix metalloproteinases and collagen catabolism |
| Q38991475 | Modulation of Systemic Metabolism by MMP-2: From MMP-2 Deficiency in Mice to MMP-2 Deficiency in Patients |
| Q77939108 | Modulation of the catalytic activity of neutrophil collagenase MMP-8 on bovine collagen I. Role of the activation cleavage and of the hemopexin-like domain |
| Q34920476 | Molecular determinants of metalloproteinase substrate specificity: matrix metalloproteinase substrate binding domains, modules, and exosites |
| Q36104645 | Multiple roles for MMPs and TIMPs in cerebral ischemia |
| Q34942174 | Neural plasticity and the brain renin-angiotensin system |
| Q36749464 | New insights into the pathogenesis and treatment of idiopathic pulmonary fibrosis: a potential role for stem cells in the lung parenchyma and implications for therapy. |
| Q34882143 | Peripheral blood stem cell mobilization. A role for CXC chemokines |
| Q34116390 | Petulant cellular acts: destroying the ECM rather than creating it. |
| Q38693670 | Phosphorylation of STAT3 at Tyr705 regulates MMP-9 production in epithelial ovarian cancer. |
| Q35007715 | Physiology and pathophysiology of matrix metalloproteases. |
| Q45144490 | Pivotal molecular determinants of peptidic and collagen triple helicase activities reside in the S3' subsite of matrix metalloproteinase 8 (MMP-8): the role of hydrogen bonding potential of ASN188 and TYR189 and the connecting cis bond |
| Q27316472 | Planarians as a model to assess in vivo the role of matrix metalloproteinase genes during homeostasis and regeneration |
| Q36689546 | Plasticity of mesangial cells: a basis for understanding pathological alterations |
| Q33608536 | Progress in matrix metalloproteinase research |
| Q44271086 | Protein engineering of the tissue inhibitor of metalloproteinase 1 (TIMP-1) inhibitory domain. In search of selective matrix metalloproteinase inhibitors |
| Q46286585 | Proteoglycans in predentin: the last 15 micrometers before mineralization |
| Q26827966 | Proteolytic processing of von Willebrand factor by adamts13 and leukocyte proteases |
| Q44268076 | Purification and characterization of catalytic domains of gelatinase A with or without fibronectin insert for high-throughput inhibitor screening |
| Q90749231 | Pyridine-Containing Macrocycles Display MMP-2/9 Inhibitory Activity and Distinct Effects on Migration and Invasion of 2D and 3D Breast Cancer Models |
| Q44734537 | Similarity of binding sites of human matrix metalloproteinases |
| Q27650403 | Solution structure of wild-type human matrix metalloproteinase 12 (MMP-12) in complex with a tight-binding inhibitor |
| Q40748215 | Storing live embryonic and adult human cartilage grafts for transplantation using a joint simulating device |
| Q34810420 | Strategies for MMP inhibition in cancer: innovations for the post-trial era. |
| Q57584591 | Structural Characterization of the Catalytic Active Site in the Latent and Active Natural Gelatinase B from Human Neutrophils |
| Q28189730 | Structural analysis of the alpha(2) integrin I domain/procollagenase-1 (matrix metalloproteinase-1) interaction |
| Q47071821 | Structural and enzymatic characterization of Drosophila Dm2-MMP, a membrane-bound matrix metalloproteinase with tissue-specific expression. |
| Q36115471 | Structural and sequence motifs of protein (histone) methylation enzymes |
| Q24646957 | Structural basis for the product specificity of histone lysine methyltransferases |
| Q33857500 | Structural basis of the endoproteinase-protein inhibitor interaction |
| Q35187217 | Structural basis of the matrix metalloproteinases and their physiological inhibitors, the tissue inhibitors of metalloproteinases |
| Q36765111 | Structural dynamics of protein lysine methylation and demethylation |
| Q47412161 | Structural insights into the binding mode of flavonols with the active site of matrix metalloproteinase-9 through molecular docking and molecular dynamic simulations studies |
| Q41771858 | Structural signatures of enzyme binding pockets from order-independent surface alignment: a study of metalloendopeptidase and NAD binding proteins |
| Q34277014 | Structure and evolutionary aspects of matrix metalloproteinases: a brief overview |
| Q35021987 | Substrate cleavage profiling suggests a distinct function of Bacteroides fragilis metalloproteinases (fragilysin and metalloproteinase II) at the microbiome-inflammation-cancer interface |
| Q45736978 | Substrate hydrolysis by matrix metalloproteinase-9. |
| Q73198574 | Synthesis and SAR of bicyclic heteroaryl hydroxamic acid MMP and TACE inhibitors |
| Q27630877 | The 1.8-A crystal structure of a matrix metalloproteinase 8-barbiturate inhibitor complex reveals a previously unobserved mechanism for collagenase substrate recognition |
| Q92049905 | The Biochemical and Functional Characterization of M28 Aminopeptidase Protein Secreted by Acanthamoeba spp. on Host Cell Interaction |
| Q24605244 | The Yersinia adhesin YadA collagen-binding domain structure is a novel left-handed parallel beta-roll |
| Q38345793 | The canonical methionine 392 of matrix metalloproteinase 2 (gelatinase A) is not required for catalytic efficiency or structural integrity: probing the role of the methionine-turn in the metzincin metalloprotease superfamily |
| Q36593636 | The impact of aryl hydrocarbon receptor signaling on matrix metabolism: implications for development and disease |
| Q28207951 | The intermediate S1' pocket of the endometase/matrilysin-2 active site revealed by enzyme inhibition kinetic studies, protein sequence analyses, and homology modeling |
| Q36350978 | The role of matrix metalloproteinases (MMPs) in human caries |
| Q35575331 | The role of the matrix metalloproteinases in human endometrial and ovarian cycles |
| Q33261566 | The roles of substrate thermal stability and P2 and P1' subsite identity on matrix metalloproteinase triple-helical peptidase activity and collagen specificity |
| Q33786342 | The tissue inhibitors of metalloproteinases (TIMPs): an ancient family with structural and functional diversity |
| Q77602143 | The up-regulation of stromelysin-1 (MMP-3) in a spontaneously demyelinating transgenic mouse precedes onset of disease |
| Q27629124 | Transfer RNA-mediated editing in threonyl-tRNA synthetase. The class II solution to the double discrimination problem |
| Q35000728 | Triple-helical peptide analysis of collagenolytic protease activity |
| Q45148767 | Uveal melanocytes produce matrix metalloproteinases-2 and -9 in vitro |
| Q35578613 | p-Coumaric Acid Attenuates UVB-Induced Release of Stratifin from Keratinocytes and Indirectly Regulates Matrix Metalloproteinase 1 Release from Fibroblasts. |
Search more.